Newswise — Surgeons at University Hospitals Cleveland Medical Center have improved the prognosis of several cardiac patients after emergency FDA approval of a diaphragm pacing device. An abstract ...

A second clinical trial of a diaphragm pacer for people with ALS has shut down early, and another hangs in limbo, as doctors and patients wonder if the surgically implanted device—meant to improve ...

A pioneering trial investigating the safety and efficacy of diaphragm pacing used to alleviate breathing difficulties for people with motor neurone disease (MND), has revealed the intervention is not ...

Diaphragmatic pacing in conjunction with non-invasive ventilation is detrimental to patients with amyotrophic lateral sclerosis (ALS) and respiratory insufficiency, show findings from a randomised ...

April 19, 2005 — Implantation of a minimally invasive diaphragm pacing system (DPS) with therapeutic electrostimulation may help maintain diaphragm function and slow or arrest the rate of respiratory ...

October 14, 2010 — The US Food and Drug Administration (FDA) has granted humanitarian use device designation for a diaphragm pacing system (NeuRx; Synapse Biomedical, Inc) in patients with amyotrophic ...

Newswise — CLEVELAND-- A medical device pioneered by University Hospitals and Case Western Reserve University has received FDA premarket approval, which opens up its use for many more patients across ...

Laparoscopic diaphragm mapping – an electronic reading of the diaphragm nerves – is safe and can be performed in multiple centers with success, a new study shows. Early diaphragm mapping can quickly ...

Please provide your email address to receive an email when new articles are posted on . Synapse Biomedical has received premarket approval from the FDA for its NeuRx Diaphragm Pacing System, which ...

A new study published in the Journal of Trauma and Acute Care Surgery finds that diaphragm pacing (DP) stimulation in spinal cord-injured patients is successful not only in weaning patients from ...